Clinical evidence for osteoarthritis as an inflammatory disease

被引:27
|
作者
Pincus T. [1 ]
机构
[1] Division of Rheumatology, Vanderbilt University Medical Center, 203 Oxford House, Box 5, Nashville, 37232-4500, TN
关键词
Acetaminophen; Etodolac; Misoprostol; Nabu; Nabumetone;
D O I
10.1007/s11926-001-0068-4
中图分类号
学科分类号
摘要
Osteoarthritis (OA) is not a simple consequence of “wear and tear” or aging—the presence of cytokines suggests a role for inflammation. OA is polyarticular in most patients, with metabolic and differential risk factors for prevalence and severity. Odds ratios for the prevalence of OA according to formal education levels are similar to those seen for dysregulatory diseases such as hypertension, diabetes, and rheumatoid arthritis. Clinical survey data indicate significant patient preference for nonsteroidal anti-inflammatory drugs (NSAIDs) compared with acetaminophen. A recent crossover clinical trial indicated significantly greater efficacy of the NSAID, diclofenac/misoprostol, versus acetaminophen for most patients with OA. © 2001, Current Science Inc.
引用
收藏
页码:524 / 534
页数:10
相关论文
共 50 条
  • [11] INFLAMMATORY OSTEOARTHRITIS .1. CLINICAL SYNDROME
    EHRLICH, GE
    JOURNAL OF CHRONIC DISEASES, 1972, 25 (6-7): : 317 - &
  • [12] CLINICAL DEFINITION AND COEFFICIENTS OF CORRELATION OF INFLAMMATORY OSTEOARTHRITIS
    EHRLICH, GE
    ARTHRITIS AND RHEUMATISM, 1971, 14 (03): : 381 - &
  • [13] Biosimilar switching in inflammatory bowel disease: from evidence to clinical practice
    Solitano, Virginia
    D'Amico, Ferdinando
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (10) : 1019 - 1028
  • [14] Is osteoarthritis a mitochondrial disease? What is the evidence
    Fernandez-Moreno, Mercedes
    Rego-Perez, Ignacio
    Blanco, Francisco J.
    CURRENT OPINION IN RHEUMATOLOGY, 2022, 34 (01) : 46 - 53
  • [15] Targeting Leukocyte Trafficking in Inflammatory Bowel Disease: What Is the Clinical Evidence?
    Khanna, Reena
    Mosli, Mahmoud H.
    Feagan, Brian G.
    DIGESTIVE DISEASES, 2015, 33 : 95 - 104
  • [16] Evidence-based clinical practice guidelines for inflammatory bowel disease
    Katsuyoshi Matsuoka
    Taku Kobayashi
    Fumiaki Ueno
    Toshiyuki Matsui
    Fumihito Hirai
    Nagamu Inoue
    Jun Kato
    Kenji Kobayashi
    Kiyonori Kobayashi
    Kazutaka Koganei
    Reiko Kunisaki
    Satoshi Motoya
    Masakazu Nagahori
    Hiroshi Nakase
    Fumio Omata
    Masayuki Saruta
    Toshiaki Watanabe
    Toshiaki Tanaka
    Takanori Kanai
    Yoshinori Noguchi
    Ken-ichi Takahashi
    Kenji Watanabe
    Toshifumi Hibi
    Yasuo Suzuki
    Mamoru Watanabe
    Kentaro Sugano
    Tooru Shimosegawa
    Journal of Gastroenterology, 2018, 53 : 305 - 353
  • [17] Evidence-based clinical practice guidelines for inflammatory bowel disease
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Ueno, Fumiaki
    Matsui, Toshiyuki
    Hirai, Fumihito
    Inoue, Nagamu
    Kato, Jun
    Kobayashi, Kenji
    Kobayashi, Kiyonori
    Koganei, Kazutaka
    Kunisaki, Reiko
    Motoya, Satoshi
    Nagahori, Masakazu
    Nakase, Hiroshi
    Omata, Fumio
    Saruta, Masayuki
    Watanabe, Toshiaki
    Tanaka, Toshiaki
    Kanai, Takanori
    Noguchi, Yoshinori
    Takahashi, Ken-ichi
    Watanabe, Kenji
    Hibi, Toshifumi
    Suzuki, Yasuo
    Watanabe, Mamoru
    Sugano, Kentaro
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (03) : 305 - 353
  • [18] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
    Hiroshi Nakase
    Motoi Uchino
    Shinichiro Shinzaki
    Minoru Matsuura
    Katsuyoshi Matsuoka
    Taku Kobayashi
    Masayuki Saruta
    Fumihito Hirai
    Keisuke Hata
    Sakiko Hiraoka
    Motohiro Esaki
    Ken Sugimoto
    Toshimitsu Fuji
    Kenji Watanabe
    Shiro Nakamura
    Nagamu Inoue
    Toshiyuki Itoh
    Makoto Naganuma
    Tadakazu Hisamatsu
    Mamoru Watanabe
    Hiroto Miwa
    Nobuyuki Enomoto
    Tooru Shimosegawa
    Kazuhiko Koike
    Journal of Gastroenterology, 2021, 56 : 489 - 526
  • [19] Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials
    Hedin, Charlotte
    Whelani, Kevin
    Lindsay, James O.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2007, 66 (03) : 307 - 315
  • [20] Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
    Jan Bilski
    Agnieszka Mazur-Bialy
    Bartosz Brzozowski
    Marcin Magierowski
    Janina Zahradnik-Bilska
    Dagmara Wójcik
    Katarzyna Magierowska
    Slawomir Kwiecien
    Tomasz Mach
    Tomasz Brzozowski
    Pharmacological Reports, 2016, 68 : 827 - 836